NCT06112873

Brief Summary

The evaluation of the quality of life (QOL) in food allergy (AA) is difficult due to the lack of a currently validated questionnaire. There are only a few tools available to assess the impact of nutritional care on the QOL of the allergic patient . Available questionnaires are poorly adapted to studies dealing with large cohorts where functionality and ease of use are determining factors. The aim of this work will be to develop and validate QOL questionnaires for AA, short and easy to use, also integrating the theme of collective catering in order to assess the evolution of QOL in patients with food allergy. The target population of the questionnaires will be: i) the parents of allergic children 0 to 17 years (15 questions) ii) allergic children aged 8 to 17 years (13 questions) iii) Adults over 18 (14 questions) After receiving an information note, eligible patients or their parents will complete the questionnaires. A total of 200 patients will be recruited for each questionnaire. A statistical evaluation will be carried out using 200 questionnaires for each targeted population in order to validate the psychometric properties of the questionnaire as well as investigate the degree of correlation between the scores of the mini-questionnaire and those obtained using the Europrevall reference questionnaire.

Trial Health

35
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
600

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Nov 2023

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

October 27, 2023

Completed
6 days until next milestone

First Posted

Study publicly available on registry

November 2, 2023

Completed
3 days until next milestone

Study Start

First participant enrolled

November 5, 2023

Completed
1 year until next milestone

Primary Completion

Last participant's last visit for primary outcome

November 5, 2024

Completed
1 year until next milestone

Study Completion

Last participant's last visit for all outcomes

November 5, 2025

Completed
Last Updated

November 2, 2023

Status Verified

June 1, 2023

Enrollment Period

1 year

First QC Date

October 27, 2023

Last Update Submit

October 27, 2023

Conditions

Keywords

Food AllergyQuality of LifeChildrenAdultSelf-reported questionnaire

Outcome Measures

Primary Outcomes (2)

  • Validity and Reliability of Questionnaires

    6 months

  • Comparability with EUROPREVALL reference questionnaires

    3 months

Secondary Outcomes (1)

  • Discriminative capacity of questionnaires

    3 months

Study Arms (3)

The parents of allergic children 0 to 17 years

The parents of 200 eligible patients will complete the parent questionnaire comprising 15 questions

Other: Quality of Life Questionnaire

Allergic children aged 8 to 17 years

A total of 200 eligible patients aged 8 to 17 years will complete the children's self-reported questionnaire comprising 13 questions.

Other: Quality of Life Questionnaire

Adults over 18

A total of 200 adult patients will complete the adult self-reported questionnaire comprising 14 questions.

Other: Quality of Life Questionnaire

Interventions

Patient (or Parent)-Reported Outcomes via specific questionnaires

Adults over 18Allergic children aged 8 to 17 yearsThe parents of allergic children 0 to 17 years

Eligibility Criteria

Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Patients (or patients parents) cared for food allergy at CHU de Besançon, CHU de Toulouse, CHU Angers and CHU de Lyon including: * 200 parents of allergic children * 200 allergic children aged 8 to 17 years * 200 adults with food allergy

You may qualify if:

  • Patients with an IgE-mediated allergy to any food, or a non-IgE-mediated allergy to cow's milk in infants.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

MeSH Terms

Conditions

Food Hypersensitivity

Condition Hierarchy (Ancestors)

Hypersensitivity, ImmediateHypersensitivityImmune System Diseases

Central Study Contacts

Jean-Marc RAME, MD

CONTACT

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
OTHER
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

October 27, 2023

First Posted

November 2, 2023

Study Start

November 5, 2023

Primary Completion

November 5, 2024

Study Completion

November 5, 2025

Last Updated

November 2, 2023

Record last verified: 2023-06

Data Sharing

IPD Sharing
Will not share